|
|
Article: SAS[R] Powers Small, Midsize Biotech and Pharmaceutical Companies.
- Article from:
- Business Wire
- Article date:
- March 18, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Life Science Companies Invest More in Analytics for New Drug Development
CARY, N.C. -- Despite the recession, pharmaceutical and biotech companies continue to invest in discovery and development of advanced, life-saving therapies. Small and midsize life science firms leading the quest to deliver innovative products use SAS analytics to speed drug development and facilitate regulatory compliance.
"Drug discovery and clinical trials entail years of work and millions of start-up dollars," said Jason Burke, Worldwide Director of Health and Life Sciences at SAS. "For small and midsize firms with limited capital and staffing, ease of regulatory compliance, ...